Q2 2019 Protalix Biotherapeutics Inc Earnings Call Transcript
Good morning, ladies and gentlemen, and welcome to the Protalix Second Quarter 2019 Financial Results and Corporate Conference Call.
(Operator Instructions) As a reminder, this conference is being recorded.
I would now like to turn the conference over to our host, Mr. Lada, investor relations. You may begin your conference.
Thank you. Hello, everyone, and welcome to Protalix BioTherapeutics' Second Quarter Earnings Results and Corporate Update Conference Call.
With me today is Dror Bashan, Protalix' President and CEO.
A press release announcing the results is available on the Protalix website. Please take a moment to read the disclaimer about forward-looking statements in the press release. The earnings release and this teleconference include forward-looking statements. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual future experiences to results -- and results to differ materially from the statements made. Factors that could
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |